Annual Operating Profit
-$517.12 M
+$77.49 M+13.03%
31 December 2023
Summary:
Apellis Pharmaceuticals annual operaing income is currently -$517.12 million, with the most recent change of +$77.49 million (+13.03%) on 31 December 2023. During the last 3 years, it has fallen by -$303.39 million (-141.96%). APLS annual operating profit is now -12733.06% below its all-time high of -$4.03 million, reached on 31 December 2013.APLS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$47.28 M
-$17.84 M-60.58%
30 September 2024
Summary:
Apellis Pharmaceuticals quarterly operating income is currently -$47.28 million, with the most recent change of -$17.84 million (-60.58%) on 30 September 2024. Over the past year, it has increased by +$89.80 million (+65.51%). APLS quarterly operating profit is now -136.34% below its all-time high of $130.12 million, reached on 31 December 2020.APLS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$223.33 M
+$89.80 M+28.68%
30 September 2024
Summary:
Apellis Pharmaceuticals TTM operating income is currently -$223.33 million, with the most recent change of +$89.80 million (+28.68%) on 30 September 2024. Over the past year, it has increased by +$373.33 million (+62.57%). APLS TTM operating profit is now -8268.85% below its all-time high of -$2.67 million, reached on 30 September 2014.APLS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.0% | +65.5% | +62.6% |
| 3 y3 years | -142.0% | +63.1% | +29.5% |
| 5 y5 years | -304.2% | +32.4% | -1.9% |
APLS Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -142.0% | +13.0% | -60.6% | +73.0% | at high | +65.1% |
| 5 y | 5 years | -304.2% | +13.0% | -136.3% | +75.7% | -4.5% | +65.1% |
| alltime | all time | <-9999.0% | +13.0% | -136.3% | +75.7% | -8268.9% | +65.1% |
Apellis Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$47.28 M(+60.6%) | -$223.33 M(-28.7%) |
| June 2024 | - | -$29.44 M(-52.6%) | -$313.13 M(-22.5%) |
| Mar 2024 | - | -$62.09 M(-26.5%) | -$404.13 M(-21.9%) |
| Dec 2023 | -$517.12 M(-13.0%) | -$84.52 M(-38.3%) | -$517.12 M(-13.3%) |
| Sept 2023 | - | -$137.08 M(+13.8%) | -$596.66 M(-2.6%) |
| June 2023 | - | -$120.44 M(-31.2%) | -$612.51 M(-4.4%) |
| Mar 2023 | - | -$175.08 M(+6.7%) | -$640.70 M(+7.8%) |
| Dec 2022 | -$594.61 M(+10.9%) | -$164.05 M(+7.3%) | -$594.61 M(+14.4%) |
| Sept 2022 | - | -$152.94 M(+2.9%) | -$519.96 M(+5.0%) |
| June 2022 | - | -$148.62 M(+15.2%) | -$495.02 M(-8.4%) |
| Mar 2022 | - | -$129.00 M(+44.3%) | -$540.68 M(+0.8%) |
| Dec 2021 | -$536.28 M(+150.9%) | -$89.40 M(-30.2%) | -$536.28 M(+69.3%) |
| Sept 2021 | - | -$128.00 M(-34.1%) | -$316.75 M(-0.5%) |
| June 2021 | - | -$194.29 M(+55.9%) | -$318.31 M(+32.9%) |
| Mar 2021 | - | -$124.59 M(-195.8%) | -$239.53 M(+12.1%) |
| Dec 2020 | -$213.73 M(-25.8%) | $130.12 M(-200.4%) | -$213.72 M(-52.5%) |
| Sept 2020 | - | -$129.55 M(+12.2%) | -$449.79 M(+15.3%) |
| June 2020 | - | -$115.51 M(+16.9%) | -$390.18 M(+15.4%) |
| Mar 2020 | - | -$98.79 M(-6.8%) | -$338.15 M(+17.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$288.01 M(+125.1%) | -$105.94 M(+51.5%) | -$288.01 M(+31.4%) |
| Sept 2019 | - | -$69.95 M(+10.2%) | -$219.27 M(+18.4%) |
| June 2019 | - | -$63.48 M(+30.5%) | -$185.13 M(+19.3%) |
| Mar 2019 | - | -$48.65 M(+30.8%) | -$155.14 M(+21.3%) |
| Dec 2018 | -$127.92 M(+152.0%) | -$37.20 M(+3.9%) | -$127.92 M(+17.7%) |
| Sept 2018 | - | -$35.80 M(+6.9%) | -$108.72 M(+28.7%) |
| June 2018 | - | -$33.49 M(+56.2%) | -$84.51 M(+33.8%) |
| Mar 2018 | - | -$21.44 M(+19.1%) | -$63.15 M(+24.4%) |
| Dec 2017 | -$50.77 M(+86.1%) | -$17.99 M(+55.3%) | -$50.77 M(+28.7%) |
| Sept 2017 | - | -$11.59 M(-4.5%) | -$39.45 M(+12.4%) |
| June 2017 | - | -$12.13 M(+34.0%) | -$35.10 M(+52.8%) |
| Mar 2017 | - | -$9.05 M(+35.5%) | -$22.97 M(+65.1%) |
| Dec 2016 | -$27.28 M(+35.8%) | -$6.68 M(-7.7%) | -$13.91 M(-2.0%) |
| Sept 2016 | - | -$7.23 M(+3.9%) | -$14.20 M(+17.1%) |
| Dec 2015 | -$20.09 M(+77.9%) | -$6.96 M(+35.0%) | -$12.13 M(+50.1%) |
| Sept 2015 | - | -$5.16 M(+76.9%) | -$8.08 M(+44.6%) |
| Dec 2014 | -$11.29 M(+180.3%) | -$2.92 M(+9.3%) | -$5.59 M(+109.3%) |
| Sept 2014 | - | -$2.67 M | -$2.67 M |
| Dec 2013 | -$4.03 M | - | - |
FAQ
- What is Apellis Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual operating profit year-on-year change?
- What is Apellis Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly operating profit year-on-year change?
- What is Apellis Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals TTM operating profit year-on-year change?
What is Apellis Pharmaceuticals annual operaing income?
The current annual operating profit of APLS is -$517.12 M
What is the all time high annual operating profit for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual operaing income is -$4.03 M
What is Apellis Pharmaceuticals annual operating profit year-on-year change?
Over the past year, APLS annual operaing income has changed by +$77.49 M (+13.03%)
What is Apellis Pharmaceuticals quarterly operating income?
The current quarterly operating profit of APLS is -$47.28 M
What is the all time high quarterly operating profit for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly operating income is $130.12 M
What is Apellis Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, APLS quarterly operating income has changed by +$89.80 M (+65.51%)
What is Apellis Pharmaceuticals TTM operating income?
The current TTM operating profit of APLS is -$223.33 M
What is the all time high TTM operating profit for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high TTM operating income is -$2.67 M
What is Apellis Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, APLS TTM operating income has changed by +$373.33 M (+62.57%)